VVOS - Vivos regains compliance with Nasdaq listing rule
- Vivos Therapeutics ( NASDAQ: VVOS ) said it regained compliance with Nasdaq's rule of $1 minimum bid price requirement for continued listing on the exchnage.
- Vivos was previously notified by Nasdaq on Nov. 3, 2022 that it was not in compliance with the minimum bid price rule because its common stock failed to meet the closing bid price of $1 or more for 30 consecutive business days.
- The company noted that it was required to maintain a minimum closing bid price of $1 or more for at least 10 consecutive trading days and this requirement was met on Jan. 18.
For further details see:
Vivos regains compliance with Nasdaq listing rule